{"log_id": 2058005159180038775, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0, "average": 0.884145, "min": 0.884145}, "location": {"width": 41, "top": 65, "height": 22, "left": 1094}, "words": "局"}, {"probability": {"variance": 1e-05, "average": 0.99798, "min": 0.986853}, "location": {"width": 827, "top": 215, "height": 29, "left": 216}, "words": "一项小型随机、双盲、阳性对照试验(研究0108)中,CHB和失代偿肝病受试者接受"}, {"probability": {"variance": 0, "average": 0.999815, "min": 0.999815}, "location": {"width": 25, "top": 214, "height": 25, "left": 1149}, "words": "国"}, {"probability": {"variance": 1.5e-05, "average": 0.998244, "min": 0.980794}, "location": {"width": 817, "top": 245, "height": 28, "left": 214}, "words": "富马酸替诺福韦二吡呋酯或其他抗病毒药物治疗达48周(参见“临床研究”)。富"}, {"probability": {"variance": 1e-06, "average": 0.999319, "min": 0.99476}, "location": {"width": 836, "top": 275, "height": 27, "left": 216}, "words": "马酸替诺福韦二吡呋酯治疗组45名受试者中,最常见治疗期间出现的不良反应(任何"}, {"probability": {"variance": 6.9e-05, "average": 0.996642, "min": 0.951756}, "location": {"width": 840, "top": 302, "height": 33, "left": 213}, "words": "等级)为腹痛(22%)、恶心(20%)、失眠(18%)、瘙痒(16%)、呕吐(13%)、头"}, {"probability": {"variance": 0.000138, "average": 0.99461, "min": 0.94}, "location": {"width": 835, "top": 333, "height": 30, "left": 214}, "words": "晕(13%)和发热(11%)。截至试验第48周时,2/45(4%)例受试者因肝病进展死亡"}, {"probability": {"variance": 0.000484, "average": 0.993087, "min": 0.857631}, "location": {"width": 826, "top": 361, "height": 33, "left": 213}, "words": "3/45(7%)例受试者因不良事件终止治疗。4/45(9%)例受试者出现确证的血清肌酐"}, {"probability": {"variance": 0.00059, "average": 0.992778, "min": 0.84985}, "location": {"width": 781, "top": 391, "height": 30, "left": 212}, "words": "升高(0.5mg/dL)(截至第48周时1例受试者也出现确证的血清磷浓度小于2"}, {"probability": {"variance": 0.000254, "average": 0.991163, "min": 0.92272}, "location": {"width": 833, "top": 421, "height": 29, "left": 217}, "words": "g/dL)。其中3例受试者(入组时其 Child-Pugh评分大于或等于10,MELD评分大于"}, {"probability": {"variance": 8e-06, "average": 0.998271, "min": 0.986974}, "location": {"width": 838, "top": 448, "height": 32, "left": 212}, "words": "或等于14)出现肾衰。由于富马酸替诺福韦二吡呋酯和失代偿肝病均可能影响肾功能"}, {"probability": {"variance": 5e-06, "average": 0.998414, "min": 0.990542}, "location": {"width": 602, "top": 479, "height": 29, "left": 212}, "words": "因此难以确定富马酸替诺福韦二吡呋酯对该人群的肾损害影响"}, {"probability": {"variance": 1.2e-05, "average": 0.998095, "min": 0.985237}, "location": {"width": 590, "top": 531, "height": 31, "left": 214}, "words": "48周试验期间,45例受试者中有1例出现治疗期间肝炎发作"}, {"probability": {"variance": 8e-06, "average": 0.998501, "min": 0.986933}, "location": {"width": 462, "top": 583, "height": 28, "left": 216}, "words": "12岁及12岁以上慢性乙肝儿童受试者临床试验"}, {"probability": {"variance": 1.1e-05, "average": 0.998565, "min": 0.979139}, "location": {"width": 822, "top": 633, "height": 34, "left": 211}, "words": "不良反应评估基于一项106例儿童慢性乙肝感染受试者(12至18岁以下)接受富马"}, {"probability": {"variance": 4.7e-05, "average": 0.997805, "min": 0.957447}, "location": {"width": 787, "top": 662, "height": 33, "left": 211}, "words": "酸替诺福韦二吡呋酯(N=52)或安慰剂(N=54)72周治疗的随机研究(研究"}, {"probability": {"variance": 0.000294, "average": 0.99449, "min": 0.893857}, "location": {"width": 835, "top": 693, "height": 30, "left": 214}, "words": "115)。富马酸替诺福韦二吡呋酯治疗组儿童受试者中不良反应与成人富马酸替诺福韦"}, {"probability": {"variance": 1.6e-05, "average": 0.996986, "min": 0.987372}, "location": {"width": 334, "top": 722, "height": 27, "left": 212}, "words": "二吡呋酯临床试验中观察结果一致"}, {"probability": {"variance": 6e-06, "average": 0.998226, "min": 0.98743}, "location": {"width": 829, "top": 770, "height": 38, "left": 210}, "words": "富马酸替诺福韦二吡呋酯组受试者的骨密度平均增加率低于安慰剂组(参见“注意事"}, {"probability": {"variance": 9e-06, "average": 0.997661, "min": 0.991274}, "location": {"width": 149, "top": 803, "height": 25, "left": 211}, "words": "项,骨影响”)"}, {"probability": {"variance": 2.3e-05, "average": 0.998421, "min": 0.970431}, "location": {"width": 803, "top": 902, "height": 29, "left": 212}, "words": "上市后经验:在富马酸替诺福韦二吡呋酯获批后的使用过程中发现了下列不良反应"}, {"probability": {"variance": 1.7e-05, "average": 0.998284, "min": 0.980236}, "location": {"width": 827, "top": 931, "height": 32, "left": 210}, "words": "由于上市后反应是自发性报告,其来源的人群大小未知,所以无法可靠估计其发生频"}, {"probability": {"variance": 0.000193, "average": 0.995499, "min": 0.940528}, "location": {"width": 381, "top": 960, "height": 28, "left": 211}, "words": "率或建立其与药物暴露之间的因果关系"}, {"probability": {"variance": 1.6e-05, "average": 0.997808, "min": 0.988764}, "location": {"width": 135, "top": 1015, "height": 26, "left": 210}, "words": "免疫系统疾病"}, {"probability": {"variance": 4.2e-05, "average": 0.997028, "min": 0.976215}, "location": {"width": 271, "top": 1045, "height": 27, "left": 208}, "words": "过敏反应,包括神经性水肿"}, {"probability": {"variance": 0, "average": 0.999823, "min": 0.999549}, "location": {"width": 159, "top": 1098, "height": 26, "left": 210}, "words": "代谢和营养疾病"}, {"probability": {"variance": 0, "average": 0.975384, "min": 0.975384}, "location": {"width": 34, "top": 1097, "height": 31, "left": 1049}, "words": "交"}, {"probability": {"variance": 5e-06, "average": 0.998581, "min": 0.991057}, "location": {"width": 356, "top": 1128, "height": 27, "left": 211}, "words": "低磷血症、低钾血症、乳酸性酸中毒"}, {"probability": {"variance": 1e-06, "average": 0.999276, "min": 0.996404}, "location": {"width": 203, "top": 1181, "height": 27, "left": 209}, "words": "呼吸、胸和纵隔疾病"}, {"probability": {"variance": 0, "average": 0.999663, "min": 0.998914}, "location": {"width": 92, "top": 1210, "height": 24, "left": 209}, "words": "呼吸困难"}, {"probability": {"variance": 1e-06, "average": 0.99896, "min": 0.99723}, "location": {"width": 115, "top": 1263, "height": 25, "left": 208}, "words": "胃肠道疾病"}, {"probability": {"variance": 0.000187, "average": 0.994336, "min": 0.950892}, "location": {"width": 272, "top": 1292, "height": 27, "left": 207}, "words": "腹痛、淀粉酶升高和胰腺炎"}, {"probability": {"variance": 0.015939, "average": 0.575828, "min": 0.449578}, "location": {"width": 134, "top": 1278, "height": 50, "left": 945}, "words": "约心"}, {"probability": {"variance": 6e-06, "average": 0.998469, "min": 0.994193}, "location": {"width": 93, "top": 1347, "height": 26, "left": 207}, "words": "肝胆疾病"}, {"probability": {"variance": 0.000456, "average": 0.99412, "min": 0.873819}, "location": {"width": 819, "top": 1376, "height": 29, "left": 206}, "words": "脂肪肝、肝酶升高(最常见的谷草转氨酶、谷丙转氨酶、γ-谷酰转肽酶)、肝炎"}, {"probability": {"variance": 5e-06, "average": 0.995633, "min": 0.993341}, "location": {"width": 30, "top": 1515, "height": 22, "left": 1030}, "words": "/2"}], "language": 3}